Vaccine Efficacy in Senescent Mice Challenged With Recombinant SARS-CoV Bearing Epidemic and Zoonotic Spike Variants

PLoS Medicine - United States
doi 10.1371/journal.pmed.0030525
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Public Library of Science (PLoS)

Related search

Correction: Vaccine Efficacy in Senescent Mice Challenged With Recombinant SARS-CoV Bearing Epidemic and Zoonotic Spike Variants

PLoS Medicine
BiochemistryBiotechnologyMolecular BiologyCell BiologyMedicine
2007English

Development of a SARS Coronavirus Vaccine From Recombinant Spike Protein Plus Delta Inulin Adjuvant

Methods in Molecular Biology
GeneticsMolecular Biology
2016English

Monoclonal Antibodies for the S2 Subunit of Spike of SARS-CoV Cross-React With the Newly-Emerged SARS-CoV-2

2020English

Differential Antibody Recognition by Novel SARS-CoV-2 and SARS-CoV Spike Protein Receptor Binding Domains: Mechanistic Insights

2020English

Prior Immunization With Severe Acute Respiratory Syndrome (SARS)-Associated Coronavirus (SARS-CoV) Nucleocapsid Protein Causes Severe Pneumonia in Mice Infected With SARS-CoV

Journal of Immunology
AllergyImmunology
2008English

The SARS-CoV-2 Vaccine Pipeline: An Overview

Current Tropical Medicine Reports
Infectious DiseasesAllergyImmunology
2020English

In Silico Study of the Spike Protein From SARS-CoV-2 Interaction With ACE2: Similarity With SARS-CoV, Hot-Spot Analysis and Effect of the Receptor Polymorphism

2020English

On the Interactions of the Receptor-Binding Domain of SARS-CoV-1 and SARS-CoV-2 Spike Proteins With Monoclonal Antibodies and the Receptor ACE2

2020English

The First-In-Class Peptide Binder to the SARS-CoV-2 Spike Protein

2020English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy